A detailed history of Morgan Stanley transactions in Pfizer Inc stock. As of the latest transaction made, Morgan Stanley holds 77,971,216 shares of PFE stock, worth $1.94 Billion. This represents 0.17% of its overall portfolio holdings.

Number of Shares
77,971,216
Previous 77,472,246 0.64%
Holding current value
$1.94 Billion
Previous $2.17 Billion 4.1%
% of portfolio
0.17%
Previous 0.17%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $13.8 Million - $15.7 Million
498,970 Added 0.64%
77,971,216 $2.26 Billion
Q2 2024

Oct 17, 2024

SELL
$25.26 - $29.6 $185 Million - $217 Million
-7,320,593 Reduced 8.63%
77,472,246 $2.17 Billion
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $185 Million - $217 Million
-7,320,593 Reduced 8.63%
77,472,246 $2.17 Billion
Q1 2024

Oct 17, 2024

BUY
$25.89 - $29.73 $190 Million - $218 Million
7,320,593 Added 9.45%
84,792,839 $2.35 Billion
Q1 2024

Aug 16, 2024

BUY
$25.89 - $29.73 $69.5 Million - $79.9 Million
2,686,303 Added 3.27%
84,792,839 $2.35 Billion
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $69.5 Million - $79.9 Million
2,686,303 Added 3.27%
84,792,839 $2.35 Billion
Q4 2023

Aug 16, 2024

BUY
$26.13 - $33.94 $121 Million - $157 Million
4,634,290 Added 5.98%
82,106,536 $2.36 Billion
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $73.7 Million - $95.8 Million
-2,821,266 Reduced 3.32%
82,106,536 $2.36 Billion
Q3 2023

Nov 15, 2023

BUY
$32.09 - $37.51 $11.2 Million - $13.1 Million
348,628 Added 0.41%
84,927,802 $2.82 Billion
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $142 Million - $164 Million
3,929,745 Added 4.87%
84,579,174 $3.1 Billion
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $45.3 Million - $59 Million
1,150,068 Added 1.45%
80,649,429 $3.29 Billion
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $310 Million - $404 Million
7,419,929 Added 10.29%
79,499,361 $4.08 Billion
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $20.5 Million - $25.1 Million
-469,003 Reduced 0.65%
72,079,432 $3.15 Billion
Q2 2022

Oct 27, 2022

BUY
$46.53 - $55.17 $1.17 Billion - $1.39 Billion
25,173,688 Added 53.14%
72,548,435 $3.8 Billion
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $1.17 Billion - $1.39 Billion
25,173,688 Added 53.14%
72,548,435 $3.8 Billion
Q1 2022

Oct 27, 2022

SELL
$45.75 - $56.69 $1.15 Billion - $1.43 Billion
-25,173,688 Reduced 34.7%
47,374,747 $2.45 Billion
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $14.7 Million - $18.2 Million
320,901 Added 0.68%
47,374,747 $2.45 Billion
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $16.5 Million - $24.5 Million
399,821 Added 0.86%
47,053,846 $2.78 Billion
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $1.83 Billion - $2.35 Billion
46,654,025 New
46,654,025 $2.01 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.